Skip to menu Skip to content Skip to footer

Complement C3a receptor, a novel therapeutic target for melanoma (2014-2015)

Experts

Associate Professor Barbara Rolfe

Principal Research Fellow and Group Leader
Australian Institute for Bioengineering and Nanotechnology
Barbara Rolfe
Barbara Rolfe

Professor Andrew Barbour

Affiliate Professor of Frazer Institute
Frazer Institute
Faculty of Medicine
Professor
PA Southside Clinical Unit
Faculty of Medicine
Andrew Barbour
Andrew Barbour